Biocon Ltd, India's top-listed biotechnology firm, on Thursday said profit rose 7.4 percent in its fiscal first quarter, but lagged consensus forecasts.
Bangalore-based Biocon said consolidated net profit rose to 700.5 million rupees ($15.76 million) for the quarter ended June from 652.2 million rupees in the year-ago quarter.
A Reuters poll of brokerages had expected the company to post a net profit of 896 million rupees.
No comments:
Post a Comment